Login to Your Account



Earnings Roundup

Gilead Shows 'Truvada' Grit with Solid 3Q Earnings

By Marie Powers
Staff Writer

Thursday, October 25, 2012
Gilead Sciences Inc. did not disappoint in its third-quarter performance, reporting 14 percent higher revenues, at $2.43 billion, compared to $2.12 billion the same period a year earlier.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription